Latigo Biotherapeutics, Inc.
Pharmaceutical company · Thousand Oaks, California, United States · Nasdaq: LTGO
Latigo Biotherapeutics, Inc. is a pharmaceutical company headquartered in Thousand Oaks, California, United States. Its shares trade on Nasdaq under the ticker LTGO. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2025.
Latigo Biotherapeutics at a glance
What does Latigo Biotherapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $50 million sold (2025).
Frequently asked questions about Latigo Biotherapeutics
Where is Latigo Biotherapeutics headquartered?
Latigo Biotherapeutics, Inc. is headquartered in Thousand Oaks, California, United States.
What does Latigo Biotherapeutics do?
Latigo Biotherapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Latigo Biotherapeutics a public company?
Yes. Latigo Biotherapeutics, Inc. trades on Nasdaq under the ticker LTGO.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.